SD-101, Nivolumab, and Radiation Therapy in Treating Patients With Chemotherapy-Refractory Metastatic Pancreatic Cancer

Clinical trial NCT04050085 · COMPLETED

Trial details

NCT number: NCT04050085
Sponsor: University of California, Davis
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Refractory Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8

Start date: 2019-08-15
Primary completion: 2021-12-03
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.